Active:
1. UAB CNC Pilot Award “Microbial Biofilms as Regulators of Psychostimulant Abuse”
08/01/2024-07/31/2026; Multi-PI *Carter/Galli
2. NIH 1R21 DA059844-01 “Microbial Biofilms as Regulators of Amphetamine Use Disorders”
03/15/2024-02/27/2026; Multi-PI *Carter/Velu
3. American Cancer Society DBG-23-1152118-01-ET “A Novel Class of Microbial-based Cancer Therapy”
01/01/2024-12/31/25; Role – PI
4. NIH 1R01 DA056484-01A1 “The Role of Microbiome Composition in Amphetamine Abuse”
08/14/2023-05/31/2028; Multi-PI *Galli/Carter
Completed:
5. UAB Microbiome Center Core Services Award
8/01/2023-07/31/2024; Role – PI
4. NIH 3R01 DA038058-07A1S1 Diversity Supplement “Microbial Regulation of Psychostimulant Abuse”
06/01/2021-05/31/2023; Role – Candidate
3. UAB CAPPI Pilot Award “Microbial Regulation of Psychostimulant Abuse”
09/01/2021-08/31/2022; Role – PI
2. Sackler Foundation Research Award “Diagnostic-Coupled Targeted Drug Therapy for Neuroendocrine Cancers”
10/15/2018-10/15/2019; MPI-Carter/Bibb
1. American Cancer Society Postdoctoral Fellowship ”Identification of Therapeutic Targets for Neuroendocrine Cancer”
09/01/2015-08/31/2018; Role – PI
